IP Verse

Pharmaceutical Composition And Administrations Thereof - EP3345625

The patent EP3345625 was granted to Vertex Pharmaceuticals Incorporated on Dec 9, 2020. The application was originally filed on Aug 13, 2009 under application number EP17204189A. The patent is currently recorded with a legal status of "Revoked".

EP3345625

VERTEX PHARMACEUTICALS INCORPORATED
Application Number
EP17204189A
Filing Date
Aug 13, 2009
Status
Revoked
May 9, 2025
Grant Date
Dec 9, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

STADA ARZNEIMITTELSep 9, 2021HAMM & WITTKOPPADMISSIBLE
KRAUS & LEDERER PARTGMBBSep 7, 2021KRAUS & LEDERER PARTGMBBADMISSIBLE
TEVA PHARMACEUTICALSSep 6, 2021D YOUNGADMISSIBLE

Patent Citations (5) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2004006237
DESCRIPTIONWO2007079139
OPPOSITIONWO2007079139
OPPOSITIONWO2008080167
SEARCHWO2007079139

Non-Patent Literature (NPL) Citations (15) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- CUTTING, G. R. et al., Nature, (19900000), vol. 346, pages 366 - 369-
DESCRIPTION- DALEMANS et al., Nature Lond., (19910000), vol. 354, pages 526 - 528-
DESCRIPTION- DEAN, M. et al., Cell, (19900000), vol. 61, pages 863 - 870-
DESCRIPTION- GREGORY, R. J. et al., Nature, (19900000), vol. 347, pages 382 - 386-
DESCRIPTION- KEREM, B-S et al., Proc. Natl. Acad. Sci. USA, (19900000), vol. 87, pages 8447 - 8451-
DESCRIPTION- KEREM, B-S. et al., Science, (19890000), vol. 245, pages 1073 - 1080-
DESCRIPTION- PASYK; FOSKETT, J. Cell. Biochem., (19950000), vol. 270, pages 12347 - 50-
DESCRIPTION- QUINTON, P. M., FASEB J., (19900000), vol. 4, pages 2709 - 2727-
DESCRIPTION- RICH, D. P. et al., Nature, (19900000), vol. 347, pages 358 - 362-
DESCRIPTION- RIORDAN, J. R. et al., Science, (19890000), vol. 245, pages 1066 - 1073-
OPPOSITION- Anonymous, "Food's journey through the digestive system", Science Learning Hub, (20140423), pages 1 - 7, XP055843614-
OPPOSITION- Expert opinion- Isidoro CARABALLO-
OPPOSITION- Vasconcelos T., Sarmento B., Costa P., "Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs", DRUG DISCOVERY TODAY, (20070000), vol. 12, no. 23, pages 1068 - 1075, XP022370275-
OPPOSITION- Flume P. A., Liou T. G., Borowitz D. S., Li H., Yen K., Ordonez C. L., Geller D. E., "Ivacaftor in Subjects with cystic fibrosis who are homozygous for the F508del-CFTR mutation", Chest, (20120000), vol. 142, no. 3, pages 718 - 724, XP055842618
OPPOSITION- FLUME Patrick A., Theodore G. Liou, Drucy S. Borowitz, Haihong Li , Karl Yen, Claudia L. Ordoñez, David E. Geller, "Ivacaftor in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation", Chest, (20120000), vol. 142, no. 3, doi:10.1378/chest.11-2672, pages 718 - 724, XP055842618

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents